Top compounds associated with response to TMEM230


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.002
mRNA lapatinib CCLE pan-cancer AAC -0.14 0.002
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.1 0.003
mRNA MLN2480 CTRPv2 pan-cancer AAC 0.16 0.003
mRNA BI-2536 CTRPv2 pan-cancer AAC -0.094 0.004
mRNA 17-AAG CCLE pan-cancer AAC -0.14 0.004
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.004
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.093 0.004
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.1 0.005
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.095 0.005
Download CSV